mRNA is a rather versatile technology and offers a number of advantages. mRNA lacks genomic integration and its use results in transient expression of the encoded protein. This favorable safety profile makes mRNA especially attractive for vaccines and gene editing. mRNA is well defined chemically which ensures reproducible manufacturing at high yield, purity and activity. Improvements of lipid nanoparticle formulations as a vehicle for in vivo systemic delivery of mRNA has greatly favored the development of in vivo transfection strategies.
North America is the largest mRNA Cancer Vaccines and Therapeutics market with about 69% market share. Europe is follower, accounting for about 28% market share.
The key players are Moderna Therapeutics, CureVac, Translate Bio, BioNTech, Sangamo Therapeutics, Argos Therapeutics, In-Cell-Art, eTheRNA, Ethris, Tiba Biotechnology etc. Top 3 companies occupied about 82% market share.
Market Analysis and Insights: Global mRNA Cancer Vaccines and Therapeutics Market
The global mRNA Cancer Vaccines and Therapeutics market size is projected to reach US$ 398.8 million by 2026, from US$ 114.4 million in 2019, at a CAGR of 19.0% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global mRNA Cancer Vaccines and Therapeutics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global mRNA Cancer Vaccines and Therapeutics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global mRNA Cancer Vaccines and Therapeutics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global mRNA Cancer Vaccines and Therapeutics market.
mRNA Cancer Vaccines and Therapeutics Breakdown Data by Type
Adeno Carcinomas
Mucinous Carcinomas
Adenosquamous Carcinomas
mRNA Cancer Vaccines and Therapeutics Breakdown Data by Application
Infectious Disease
Cancer
Others
Based on regional and country-level analysis, the mRNA Cancer Vaccines and Therapeutics market has been segmented as follows:
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa
In the competitive analysis section of the report, leading as well as prominent players of the global mRNA Cancer Vaccines and Therapeutics market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2016-2021. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2016-2021.
The following players are covered in this report:
Moderna Therapeutics
CureVac
Translate Bio
BioNTech
Sangamo Therapeutics
Argos Therapeutics
In-Cell-Art
eTheRNA
Ethris
Tiba Biotechnology
North America is the largest mRNA Cancer Vaccines and Therapeutics market with about 69% market share. Europe is follower, accounting for about 28% market share.
The key players are Moderna Therapeutics, CureVac, Translate Bio, BioNTech, Sangamo Therapeutics, Argos Therapeutics, In-Cell-Art, eTheRNA, Ethris, Tiba Biotechnology etc. Top 3 companies occupied about 82% market share.
Market Analysis and Insights: Global mRNA Cancer Vaccines and Therapeutics Market
The global mRNA Cancer Vaccines and Therapeutics market size is projected to reach US$ 398.8 million by 2026, from US$ 114.4 million in 2019, at a CAGR of 19.0% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global mRNA Cancer Vaccines and Therapeutics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global mRNA Cancer Vaccines and Therapeutics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global mRNA Cancer Vaccines and Therapeutics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global mRNA Cancer Vaccines and Therapeutics market.
mRNA Cancer Vaccines and Therapeutics Breakdown Data by Type
Adeno Carcinomas
Mucinous Carcinomas
Adenosquamous Carcinomas
mRNA Cancer Vaccines and Therapeutics Breakdown Data by Application
Infectious Disease
Cancer
Others
Based on regional and country-level analysis, the mRNA Cancer Vaccines and Therapeutics market has been segmented as follows:
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa
In the competitive analysis section of the report, leading as well as prominent players of the global mRNA Cancer Vaccines and Therapeutics market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2016-2021. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2016-2021.
The following players are covered in this report:
Moderna Therapeutics
CureVac
Translate Bio
BioNTech
Sangamo Therapeutics
Argos Therapeutics
In-Cell-Art
eTheRNA
Ethris
Tiba Biotechnology
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global mRNA Cancer Vaccines and Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Adeno Carcinomas
1.2.3 Mucinous Carcinomas
1.2.4 Adenosquamous Carcinomas
1.3 Market by Application
1.3.1 Global mRNA Cancer Vaccines and Therapeutics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Infectious Disease
1.3.3 Cancer
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global mRNA Cancer Vaccines and Therapeutics Market Perspective (2016-2027)
2.2 mRNA Cancer Vaccines and Therapeutics Growth Trends by Regions
2.2.1 mRNA Cancer Vaccines and Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 mRNA Cancer Vaccines and Therapeutics Historic Market Share by Regions (2016-2021)
2.2.3 mRNA Cancer Vaccines and Therapeutics Forecasted Market Size by Regions (2022-2027)
2.3 mRNA Cancer Vaccines and Therapeutics Industry Dynamic
2.3.1 mRNA Cancer Vaccines and Therapeutics Market Trends
2.3.2 mRNA Cancer Vaccines and Therapeutics Market Drivers
2.3.3 mRNA Cancer Vaccines and Therapeutics Market Challenges
2.3.4 mRNA Cancer Vaccines and Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top mRNA Cancer Vaccines and Therapeutics Players by Revenue
3.1.1 Global Top mRNA Cancer Vaccines and Therapeutics Players by Revenue (2016-2021)
3.1.2 Global mRNA Cancer Vaccines and Therapeutics Revenue Market Share by Players (2016-2021)
3.2 Global mRNA Cancer Vaccines and Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by mRNA Cancer Vaccines and Therapeutics Revenue
3.4 Global mRNA Cancer Vaccines and Therapeutics Market Concentration Ratio
3.4.1 Global mRNA Cancer Vaccines and Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by mRNA Cancer Vaccines and Therapeutics Revenue in 2020
3.5 mRNA Cancer Vaccines and Therapeutics Key Players Head office and Area Served
3.6 Key Players mRNA Cancer Vaccines and Therapeutics Product Solution and Service
3.7 Date of Enter into mRNA Cancer Vaccines and Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 mRNA Cancer Vaccines and Therapeutics Breakdown Data by Type
4.1 Global mRNA Cancer Vaccines and Therapeutics Historic Market Size by Type (2016-2021)
4.2 Global mRNA Cancer Vaccines and Therapeutics Forecasted Market Size by Type (2022-2027)
5 mRNA Cancer Vaccines and Therapeutics Breakdown Data by Application
5.1 Global mRNA Cancer Vaccines and Therapeutics Historic Market Size by Application (2016-2021)
5.2 Global mRNA Cancer Vaccines and Therapeutics Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America mRNA Cancer Vaccines and Therapeutics Market Size (2016-2027)
6.2 North America mRNA Cancer Vaccines and Therapeutics Market Size by Type
6.2.1 North America mRNA Cancer Vaccines and Therapeutics Market Size by Type (2016-2021)
6.2.2 North America mRNA Cancer Vaccines and Therapeutics Market Size by Type (2022-2027)
6.2.3 North America mRNA Cancer Vaccines and Therapeutics Market Size by Type (2016-2027)
6.3 North America mRNA Cancer Vaccines and Therapeutics Market Size by Application
6.3.1 North America mRNA Cancer Vaccines and Therapeutics Market Size by Application (2016-2021)
6.3.2 North America mRNA Cancer Vaccines and Therapeutics Market Size by Application (2022-2027)
6.3.3 North America mRNA Cancer Vaccines and Therapeutics Market Size by Application (2016-2027)
6.4 North America mRNA Cancer Vaccines and Therapeutics Market Size by Country
6.4.1 North America mRNA Cancer Vaccines and Therapeutics Market Size by Country (2016-2021)
6.4.2 North America mRNA Cancer Vaccines and Therapeutics Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe mRNA Cancer Vaccines and Therapeutics Market Size (2016-2027)
7.2 Europe mRNA Cancer Vaccines and Therapeutics Market Size by Type
7.2.1 Europe mRNA Cancer Vaccines and Therapeutics Market Size by Type (2016-2021)
7.2.2 Europe mRNA Cancer Vaccines and Therapeutics Market Size by Type (2022-2027)
7.2.3 Europe mRNA Cancer Vaccines and Therapeutics Market Size by Type (2016-2027)
7.3 Europe mRNA Cancer Vaccines and Therapeutics Market Size by Application
7.3.1 Europe mRNA Cancer Vaccines and Therapeutics Market Size by Application (2016-2021)
7.3.2 Europe mRNA Cancer Vaccines and Therapeutics Market Size by Application (2022-2027)
7.3.3 Europe mRNA Cancer Vaccines and Therapeutics Market Size by Application (2016-2027)
7.4 Europe mRNA Cancer Vaccines and Therapeutics Market Size by Country
7.4.1 Europe mRNA Cancer Vaccines and Therapeutics Market Size by Country (2016-2021)
7.4.2 Europe mRNA Cancer Vaccines and Therapeutics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific mRNA Cancer Vaccines and Therapeutics Market Size (2016-2027)
8.2 Asia-Pacific mRNA Cancer Vaccines and Therapeutics Market Size by Type
8.2.1 Asia-Pacific mRNA Cancer Vaccines and Therapeutics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific mRNA Cancer Vaccines and Therapeutics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific mRNA Cancer Vaccines and Therapeutics Market Size by Type (2016-2027)
8.3 Asia-Pacific mRNA Cancer Vaccines and Therapeutics Market Size by Application
8.3.1 Asia-Pacific mRNA Cancer Vaccines and Therapeutics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific mRNA Cancer Vaccines and Therapeutics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific mRNA Cancer Vaccines and Therapeutics Market Size by Application (2016-2027)
8.4 Asia-Pacific mRNA Cancer Vaccines and Therapeutics Market Size by Region
8.4.1 Asia-Pacific mRNA Cancer Vaccines and Therapeutics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific mRNA Cancer Vaccines and Therapeutics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America mRNA Cancer Vaccines and Therapeutics Market Size (2016-2027)
9.2 Latin America mRNA Cancer Vaccines and Therapeutics Market Size by Type
9.2.1 Latin America mRNA Cancer Vaccines and Therapeutics Market Size by Type (2016-2021)
9.2.2 Latin America mRNA Cancer Vaccines and Therapeutics Market Size by Type (2022-2027)
9.2.3 Latin America mRNA Cancer Vaccines and Therapeutics Market Size by Type (2016-2027)
9.3 Latin America mRNA Cancer Vaccines and Therapeutics Market Size by Application
9.3.1 Latin America mRNA Cancer Vaccines and Therapeutics Market Size by Application (2016-2021)
9.3.2 Latin America mRNA Cancer Vaccines and Therapeutics Market Size by Application (2022-2027)
9.3.3 Latin America mRNA Cancer Vaccines and Therapeutics Market Size by Application (2016-2027)
9.4 Latin America mRNA Cancer Vaccines and Therapeutics Market Size by Country
9.4.1 Latin America mRNA Cancer Vaccines and Therapeutics Market Size by Country (2016-2021)
9.4.2 Latin America mRNA Cancer Vaccines and Therapeutics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa mRNA Cancer Vaccines and Therapeutics Market Size (2016-2027)
10.2 Middle East & Africa mRNA Cancer Vaccines and Therapeutics Market Size by Type
10.2.1 Middle East & Africa mRNA Cancer Vaccines and Therapeutics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa mRNA Cancer Vaccines and Therapeutics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa mRNA Cancer Vaccines and Therapeutics Market Size by Type (2016-2027)
10.3 Middle East & Africa mRNA Cancer Vaccines and Therapeutics Market Size by Application
10.3.1 Middle East & Africa mRNA Cancer Vaccines and Therapeutics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa mRNA Cancer Vaccines and Therapeutics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa mRNA Cancer Vaccines and Therapeutics Market Size by Application (2016-2027)
10.4 Middle East & Africa mRNA Cancer Vaccines and Therapeutics Market Size by Country
10.4.1 Middle East & Africa mRNA Cancer Vaccines and Therapeutics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa mRNA Cancer Vaccines and Therapeutics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Moderna Therapeutics
11.1.1 Moderna Therapeutics Company Details
11.1.2 Moderna Therapeutics Business Overview
11.1.3 Moderna Therapeutics mRNA Cancer Vaccines and Therapeutics Introduction
11.1.4 Moderna Therapeutics Revenue in mRNA Cancer Vaccines and Therapeutics Business (2016-2021)
11.1.5 Moderna Therapeutics Recent Development
11.2 CureVac
11.2.1 CureVac Company Details
11.2.2 CureVac Business Overview
11.2.3 CureVac mRNA Cancer Vaccines and Therapeutics Introduction
11.2.4 CureVac Revenue in mRNA Cancer Vaccines and Therapeutics Business (2016-2021)
11.2.5 CureVac Recent Development
11.3 Translate Bio
11.3.1 Translate Bio Company Details
11.3.2 Translate Bio Business Overview
11.3.3 Translate Bio mRNA Cancer Vaccines and Therapeutics Introduction
11.3.4 Translate Bio Revenue in mRNA Cancer Vaccines and Therapeutics Business (2016-2021)
11.3.5 Translate Bio Recent Development
11.4 BioNTech
11.4.1 BioNTech Company Details
11.4.2 BioNTech Business Overview
11.4.3 BioNTech mRNA Cancer Vaccines and Therapeutics Introduction
11.4.4 BioNTech Revenue in mRNA Cancer Vaccines and Therapeutics Business (2016-2021)
11.4.5 BioNTech Recent Development
11.5 Sangamo Therapeutics
11.5.1 Sangamo Therapeutics Company Details
11.5.2 Sangamo Therapeutics Business Overview
11.5.3 Sangamo Therapeutics mRNA Cancer Vaccines and Therapeutics Introduction
11.5.4 Sangamo Therapeutics Revenue in mRNA Cancer Vaccines and Therapeutics Business (2016-2021)
11.5.5 Sangamo Therapeutics Recent Development
11.6 Argos Therapeutics
11.6.1 Argos Therapeutics Company Details
11.6.2 Argos Therapeutics Business Overview
11.6.3 Argos Therapeutics mRNA Cancer Vaccines and Therapeutics Introduction
11.6.4 Argos Therapeutics Revenue in mRNA Cancer Vaccines and Therapeutics Business (2016-2021)
11.6.5 Argos Therapeutics Recent Development
11.7 In-Cell-Art
11.7.1 In-Cell-Art Company Details
11.7.2 In-Cell-Art Business Overview
11.7.3 In-Cell-Art mRNA Cancer Vaccines and Therapeutics Introduction
11.7.4 In-Cell-Art Revenue in mRNA Cancer Vaccines and Therapeutics Business (2016-2021)
11.7.5 In-Cell-Art Recent Development
11.8 eTheRNA
11.8.1 eTheRNA Company Details
11.8.2 eTheRNA Business Overview
11.8.3 eTheRNA mRNA Cancer Vaccines and Therapeutics Introduction
11.8.4 eTheRNA Revenue in mRNA Cancer Vaccines and Therapeutics Business (2016-2021)
11.8.5 eTheRNA Recent Development
11.9 Ethris
11.9.1 Ethris Company Details
11.9.2 Ethris Business Overview
11.9.3 Ethris mRNA Cancer Vaccines and Therapeutics Introduction
11.9.4 Ethris Revenue in mRNA Cancer Vaccines and Therapeutics Business (2016-2021)
11.9.5 Ethris Recent Development
11.10 Tiba Biotechnology
11.10.1 Tiba Biotechnology Company Details
11.10.2 Tiba Biotechnology Business Overview
11.10.3 Tiba Biotechnology mRNA Cancer Vaccines and Therapeutics Introduction
11.10.4 Tiba Biotechnology Revenue in mRNA Cancer Vaccines and Therapeutics Business (2016-2021)
11.10.5 Tiba Biotechnology Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global mRNA Cancer Vaccines and Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Adeno Carcinomas
1.2.3 Mucinous Carcinomas
1.2.4 Adenosquamous Carcinomas
1.3 Market by Application
1.3.1 Global mRNA Cancer Vaccines and Therapeutics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Infectious Disease
1.3.3 Cancer
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global mRNA Cancer Vaccines and Therapeutics Market Perspective (2016-2027)
2.2 mRNA Cancer Vaccines and Therapeutics Growth Trends by Regions
2.2.1 mRNA Cancer Vaccines and Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 mRNA Cancer Vaccines and Therapeutics Historic Market Share by Regions (2016-2021)
2.2.3 mRNA Cancer Vaccines and Therapeutics Forecasted Market Size by Regions (2022-2027)
2.3 mRNA Cancer Vaccines and Therapeutics Industry Dynamic
2.3.1 mRNA Cancer Vaccines and Therapeutics Market Trends
2.3.2 mRNA Cancer Vaccines and Therapeutics Market Drivers
2.3.3 mRNA Cancer Vaccines and Therapeutics Market Challenges
2.3.4 mRNA Cancer Vaccines and Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top mRNA Cancer Vaccines and Therapeutics Players by Revenue
3.1.1 Global Top mRNA Cancer Vaccines and Therapeutics Players by Revenue (2016-2021)
3.1.2 Global mRNA Cancer Vaccines and Therapeutics Revenue Market Share by Players (2016-2021)
3.2 Global mRNA Cancer Vaccines and Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by mRNA Cancer Vaccines and Therapeutics Revenue
3.4 Global mRNA Cancer Vaccines and Therapeutics Market Concentration Ratio
3.4.1 Global mRNA Cancer Vaccines and Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by mRNA Cancer Vaccines and Therapeutics Revenue in 2020
3.5 mRNA Cancer Vaccines and Therapeutics Key Players Head office and Area Served
3.6 Key Players mRNA Cancer Vaccines and Therapeutics Product Solution and Service
3.7 Date of Enter into mRNA Cancer Vaccines and Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 mRNA Cancer Vaccines and Therapeutics Breakdown Data by Type
4.1 Global mRNA Cancer Vaccines and Therapeutics Historic Market Size by Type (2016-2021)
4.2 Global mRNA Cancer Vaccines and Therapeutics Forecasted Market Size by Type (2022-2027)
5 mRNA Cancer Vaccines and Therapeutics Breakdown Data by Application
5.1 Global mRNA Cancer Vaccines and Therapeutics Historic Market Size by Application (2016-2021)
5.2 Global mRNA Cancer Vaccines and Therapeutics Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America mRNA Cancer Vaccines and Therapeutics Market Size (2016-2027)
6.2 North America mRNA Cancer Vaccines and Therapeutics Market Size by Type
6.2.1 North America mRNA Cancer Vaccines and Therapeutics Market Size by Type (2016-2021)
6.2.2 North America mRNA Cancer Vaccines and Therapeutics Market Size by Type (2022-2027)
6.2.3 North America mRNA Cancer Vaccines and Therapeutics Market Size by Type (2016-2027)
6.3 North America mRNA Cancer Vaccines and Therapeutics Market Size by Application
6.3.1 North America mRNA Cancer Vaccines and Therapeutics Market Size by Application (2016-2021)
6.3.2 North America mRNA Cancer Vaccines and Therapeutics Market Size by Application (2022-2027)
6.3.3 North America mRNA Cancer Vaccines and Therapeutics Market Size by Application (2016-2027)
6.4 North America mRNA Cancer Vaccines and Therapeutics Market Size by Country
6.4.1 North America mRNA Cancer Vaccines and Therapeutics Market Size by Country (2016-2021)
6.4.2 North America mRNA Cancer Vaccines and Therapeutics Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe mRNA Cancer Vaccines and Therapeutics Market Size (2016-2027)
7.2 Europe mRNA Cancer Vaccines and Therapeutics Market Size by Type
7.2.1 Europe mRNA Cancer Vaccines and Therapeutics Market Size by Type (2016-2021)
7.2.2 Europe mRNA Cancer Vaccines and Therapeutics Market Size by Type (2022-2027)
7.2.3 Europe mRNA Cancer Vaccines and Therapeutics Market Size by Type (2016-2027)
7.3 Europe mRNA Cancer Vaccines and Therapeutics Market Size by Application
7.3.1 Europe mRNA Cancer Vaccines and Therapeutics Market Size by Application (2016-2021)
7.3.2 Europe mRNA Cancer Vaccines and Therapeutics Market Size by Application (2022-2027)
7.3.3 Europe mRNA Cancer Vaccines and Therapeutics Market Size by Application (2016-2027)
7.4 Europe mRNA Cancer Vaccines and Therapeutics Market Size by Country
7.4.1 Europe mRNA Cancer Vaccines and Therapeutics Market Size by Country (2016-2021)
7.4.2 Europe mRNA Cancer Vaccines and Therapeutics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific mRNA Cancer Vaccines and Therapeutics Market Size (2016-2027)
8.2 Asia-Pacific mRNA Cancer Vaccines and Therapeutics Market Size by Type
8.2.1 Asia-Pacific mRNA Cancer Vaccines and Therapeutics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific mRNA Cancer Vaccines and Therapeutics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific mRNA Cancer Vaccines and Therapeutics Market Size by Type (2016-2027)
8.3 Asia-Pacific mRNA Cancer Vaccines and Therapeutics Market Size by Application
8.3.1 Asia-Pacific mRNA Cancer Vaccines and Therapeutics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific mRNA Cancer Vaccines and Therapeutics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific mRNA Cancer Vaccines and Therapeutics Market Size by Application (2016-2027)
8.4 Asia-Pacific mRNA Cancer Vaccines and Therapeutics Market Size by Region
8.4.1 Asia-Pacific mRNA Cancer Vaccines and Therapeutics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific mRNA Cancer Vaccines and Therapeutics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America mRNA Cancer Vaccines and Therapeutics Market Size (2016-2027)
9.2 Latin America mRNA Cancer Vaccines and Therapeutics Market Size by Type
9.2.1 Latin America mRNA Cancer Vaccines and Therapeutics Market Size by Type (2016-2021)
9.2.2 Latin America mRNA Cancer Vaccines and Therapeutics Market Size by Type (2022-2027)
9.2.3 Latin America mRNA Cancer Vaccines and Therapeutics Market Size by Type (2016-2027)
9.3 Latin America mRNA Cancer Vaccines and Therapeutics Market Size by Application
9.3.1 Latin America mRNA Cancer Vaccines and Therapeutics Market Size by Application (2016-2021)
9.3.2 Latin America mRNA Cancer Vaccines and Therapeutics Market Size by Application (2022-2027)
9.3.3 Latin America mRNA Cancer Vaccines and Therapeutics Market Size by Application (2016-2027)
9.4 Latin America mRNA Cancer Vaccines and Therapeutics Market Size by Country
9.4.1 Latin America mRNA Cancer Vaccines and Therapeutics Market Size by Country (2016-2021)
9.4.2 Latin America mRNA Cancer Vaccines and Therapeutics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa mRNA Cancer Vaccines and Therapeutics Market Size (2016-2027)
10.2 Middle East & Africa mRNA Cancer Vaccines and Therapeutics Market Size by Type
10.2.1 Middle East & Africa mRNA Cancer Vaccines and Therapeutics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa mRNA Cancer Vaccines and Therapeutics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa mRNA Cancer Vaccines and Therapeutics Market Size by Type (2016-2027)
10.3 Middle East & Africa mRNA Cancer Vaccines and Therapeutics Market Size by Application
10.3.1 Middle East & Africa mRNA Cancer Vaccines and Therapeutics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa mRNA Cancer Vaccines and Therapeutics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa mRNA Cancer Vaccines and Therapeutics Market Size by Application (2016-2027)
10.4 Middle East & Africa mRNA Cancer Vaccines and Therapeutics Market Size by Country
10.4.1 Middle East & Africa mRNA Cancer Vaccines and Therapeutics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa mRNA Cancer Vaccines and Therapeutics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Moderna Therapeutics
11.1.1 Moderna Therapeutics Company Details
11.1.2 Moderna Therapeutics Business Overview
11.1.3 Moderna Therapeutics mRNA Cancer Vaccines and Therapeutics Introduction
11.1.4 Moderna Therapeutics Revenue in mRNA Cancer Vaccines and Therapeutics Business (2016-2021)
11.1.5 Moderna Therapeutics Recent Development
11.2 CureVac
11.2.1 CureVac Company Details
11.2.2 CureVac Business Overview
11.2.3 CureVac mRNA Cancer Vaccines and Therapeutics Introduction
11.2.4 CureVac Revenue in mRNA Cancer Vaccines and Therapeutics Business (2016-2021)
11.2.5 CureVac Recent Development
11.3 Translate Bio
11.3.1 Translate Bio Company Details
11.3.2 Translate Bio Business Overview
11.3.3 Translate Bio mRNA Cancer Vaccines and Therapeutics Introduction
11.3.4 Translate Bio Revenue in mRNA Cancer Vaccines and Therapeutics Business (2016-2021)
11.3.5 Translate Bio Recent Development
11.4 BioNTech
11.4.1 BioNTech Company Details
11.4.2 BioNTech Business Overview
11.4.3 BioNTech mRNA Cancer Vaccines and Therapeutics Introduction
11.4.4 BioNTech Revenue in mRNA Cancer Vaccines and Therapeutics Business (2016-2021)
11.4.5 BioNTech Recent Development
11.5 Sangamo Therapeutics
11.5.1 Sangamo Therapeutics Company Details
11.5.2 Sangamo Therapeutics Business Overview
11.5.3 Sangamo Therapeutics mRNA Cancer Vaccines and Therapeutics Introduction
11.5.4 Sangamo Therapeutics Revenue in mRNA Cancer Vaccines and Therapeutics Business (2016-2021)
11.5.5 Sangamo Therapeutics Recent Development
11.6 Argos Therapeutics
11.6.1 Argos Therapeutics Company Details
11.6.2 Argos Therapeutics Business Overview
11.6.3 Argos Therapeutics mRNA Cancer Vaccines and Therapeutics Introduction
11.6.4 Argos Therapeutics Revenue in mRNA Cancer Vaccines and Therapeutics Business (2016-2021)
11.6.5 Argos Therapeutics Recent Development
11.7 In-Cell-Art
11.7.1 In-Cell-Art Company Details
11.7.2 In-Cell-Art Business Overview
11.7.3 In-Cell-Art mRNA Cancer Vaccines and Therapeutics Introduction
11.7.4 In-Cell-Art Revenue in mRNA Cancer Vaccines and Therapeutics Business (2016-2021)
11.7.5 In-Cell-Art Recent Development
11.8 eTheRNA
11.8.1 eTheRNA Company Details
11.8.2 eTheRNA Business Overview
11.8.3 eTheRNA mRNA Cancer Vaccines and Therapeutics Introduction
11.8.4 eTheRNA Revenue in mRNA Cancer Vaccines and Therapeutics Business (2016-2021)
11.8.5 eTheRNA Recent Development
11.9 Ethris
11.9.1 Ethris Company Details
11.9.2 Ethris Business Overview
11.9.3 Ethris mRNA Cancer Vaccines and Therapeutics Introduction
11.9.4 Ethris Revenue in mRNA Cancer Vaccines and Therapeutics Business (2016-2021)
11.9.5 Ethris Recent Development
11.10 Tiba Biotechnology
11.10.1 Tiba Biotechnology Company Details
11.10.2 Tiba Biotechnology Business Overview
11.10.3 Tiba Biotechnology mRNA Cancer Vaccines and Therapeutics Introduction
11.10.4 Tiba Biotechnology Revenue in mRNA Cancer Vaccines and Therapeutics Business (2016-2021)
11.10.5 Tiba Biotechnology Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
